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Abstract An essential step in the pathogenesis of Salmonella
enterica infections is bacterial entry into non-phagocytic cells of
the intestinal epithelium. Proteins injected by Salmonella into
host cells stimulate cellular responses that lead to extensive actin
cytoskeleton reorganization and subsequent bacterial uptake.
One of these proteins, SipA, modulates actin dynamics by
directly binding to F-actin. We have biophysically characterized
a C-terminal fragment, SipA446ÿ684, which has previously been
shown to retain activity. Our results show that SipA446ÿ684
exhibits an elongated shape with a predominantly helical
conformation and predict the existence of a coiled-coil domain.
We suggest that the protein is able to span two adjacent actin
monomers in a filament and propose a model that is consistent
with the observed effects of SipA446ÿ684 on actin dynamics and
F-actin stability and morphology. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Salmonella enterica, the causative agent of a variety of dis-
eases such as typhoid fever or food poisoning, has evolved
sophisticated strategies to modulate host cellular functions
[1]. One of these strategies allows these bacteria to manipulate
the actin cytoskeleton to enter into non-phagocytic cells such
as those of the intestinal epithelium [2]. Bacterial internaliza-
tion is the consequence of the sequential activity of a number
of bacterial proteins that are delivered into the host cell by a
specialized bacterial organelle termed the type III secretion
system [3]. These bacterial proteins include an exchange factor
(SopE) [4], a GTPase-activating protein (SptP) [5] for Cdc42
and Rac, an inositol phosphate polyphosphatase (SopB) [6]
and an actin-binding protein (SipA) [7]. The combined activity
of these bacterial e¡ectors results in the activation of the small
molecular weight GTP-binding proteins Cdc42 and Rac and
the stimulation of actin cytoskeleton rearrangements that lead
to bacterial uptake [2,8^10].
Previous studies have shown that the Salmonella SipA pro-
tein binds to actin during bacterial infection [7]. In vitro stud-
ies have demonstrated that the binding of SipA to F-actin (1:1
molar ratio) has marked e¡ects on actin dynamics, i.e. the
concentration of G-actin required for polymerization (critical
concentration) is reduced 10-fold (from 0.25 WM to 0.02 WM),
and also on F-actin stabilization, i.e. depolymerization of
F-actin induced by low ionic strength is inhibited. Further-
more, SipA-binding to actin results in a marked increase in
the actin-bundling activity of other actin-binding proteins
such as ¢mbrin [11]. It has been hypothesized that such mod-
ulation of the activity of other actin-binding proteins may be
the result of the e¡ect of SipA on the structure of the F-actin
¢lament itself [11]. Indeed, electron microscopic studies have
shown that the binding of SipA to F-actin leads to a signi¢-
cant straightening of actin ¢laments, which presumably facil-
itates the function of actin cross-linking proteins such as ¢m-
brin [11]. Deletion analysis has established that the actin-
modulating activity of SipA is contained within the last 238
amino acids (SipA446ÿ684), suggesting that the amino-terminal
half of this protein may be involved in other biological activ-
ities or in the regulation of SipA function in vivo [7]. The
biological consequence of SipA activity is a marked increase
in the e⁄ciency of bacterial internalization by non-phagocytic
cells, since Salmonella strains carrying a loss-of-function mu-
tation in sipA are signi¢cantly reduced in their ability to gain
access into host cells [7].
Understanding the precise mechanism of action of SipA is
of great interest since this is the ¢rst and only bacterially
encoded actin-binding protein that has been shown to in£u-
ence actin dynamics. In addition, amino acid sequence analy-
sis has not revealed the presence of sequences similar to
known actin-binding motifs, suggesting the possibility that
SipA exerts its actin-modulating function in a unique manner.
We have carried out a biophysical analysis of the functional
C-terminal fragment of SipA, SipA446ÿ684, using multiangle
laser light scattering (MALLS), small angle X-ray scattering
(SAXS) and circular dichroism (CD) in an e¡ort to elucidate
structural aspects of SipA446ÿ684 that may help the under-
standing of its biological activities.
2. Materials and methods
2.1. Puri¢cation of recombinant SipA protein from Escherichia coli
A fusion between glutathione-S-transferase (GST) and the C-termi-
nal 226 amino acids of SipA (GST-SipA446ÿ684) was puri¢ed as de-
scribed [7] using glutathione Sepharose 4B (Pharmacia, Piscataway,
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NJ, USA). The SipA446ÿ684 fragment was released from the GST
moiety by thrombin cleavage and puri¢ed away from thrombin by
a⁄nity chromatography through a benzamidine Sepharose 6B column
(Pharmacia Biotech, Piscataway, NJ, USA). SipA446ÿ684 was further
puri¢ed by size exclusion chromatography at 4‡C through a Superdex
75PG column in 150 mM NaCl, 50 mM MES, pH 7.0. The purity of
the resulting preparation was greater than 95% as indicated by SDS^
PAGE analysis (data not shown).
2.2. Mass determination by MALLS
To determine the molecular mass of SipA446ÿ684, the puri¢ed pro-
tein was analyzed on an HR-10/30 Superdex-200 size exclusion col-
umn connected to ultra violet (UV), MALLS and refractive index
detectors. The sample was loaded at 312 WM in 50 mM MES,
150 mM NaCl, 5 mM dithiothreitol (DTT), pH 7.0. Light scattering
and di¡erential refractometry were carried out using the Mini-Dawn
and Optilab instruments of Wyatt Technology Corp. Analysis was
carried out as described by Astra software [12]. Protein concentration
was determined by amino acid analysis performed at the W.M. Keck
Foundation Biotechnology Resource Laboratory at Yale University.
2.3. SAXS
SAXS measurements of SipA446ÿ684 were performed at 624 WM
(15.9 mg/ml) and 312 WM (7.95 mg/ml) in 50 mM MES, 150 mM
NaCl, 5 mM DTT, pH 7.0 at 25‡C. The SAXS instrument and ex-
perimental methods used were as described before [13]. The X-ray
beam was circularly collimated. The sample to detector distance was
2.3 m, enabling the measurement of an e¡ective Q range of 0.015^
0.30 Aî . Q = 4Zsina/V is the magnitude of the scattering vector, where
2a is the scattering angle and V= 1.54 Aî is the wavelength of the
X-rays. The P(r) function was generated from the scattering data by
the GNOM program [14]. Shape determination was performed using
the program DAMMIN [15].
2.4. CD
The CD spectrum of SipA446ÿ684 was recorded at 25‡C at a protein
concentration of 7.8 WM in phosphate-bu¡ered saline (150 mM NaCl,
16 mM Na2HPO4, 4 mM NaH2PO4). The spectrum was obtained by
averaging over ¢ve scans with a step size of 1 nm and an averaging
time of 4 s on an AVIV model 62DS CD spectrometer. Measurements
were preformed in a Hellma quartz cuvette of path length 0.1 cm.
Helix content was calculated from the molar ellipticity at 208 nm [16].
3. Results
As part of the puri¢cation process, SipA446ÿ684 was sub-
jected to size exclusion chromatography, where the protein
eluted at a position of higher apparent molecular mass (based
on globular protein mass standards) than the mass expected
from its predicted amino acid sequence (data not shown).
We therefore determined the absolute molecular mass of
SipA446ÿ684 by MALLS, a technique which does not rely on
the shape of the molecule. SipA446ÿ684 eluted as a monomeric
species of molecular mass 24 kDa (Fig. 1) which is in good
agreement with the molecular mass determined by mass spec-
trometry (25.6 kDa, data not shown). To reconcile the size
exclusion chromatography results with the MALLS results,
we performed SAXS measurements on SipA446ÿ684. SAXS
measures molecular weight, size and shape of a molecule,
and gives information about the global conformation of a
protein in solution. Two protein concentrations were used:
15.9 mg/ml and 7.95 mg/ml. The average radius of gyration,
Rg, obtained from both the Guinier approximation (Fig. 2A)
and the length distribution function P(r) (Fig. 2B) was 27 Aî
from measurements at both concentrations (Fig. 2 shows the
results for [SipA446ÿ684] = 15.9 mg/ml). The skewed shape of
the P(r) function for SipA446ÿ684 suggests an elongated shape,
which is corroborated by the maximum diameter (Dmax) of
Fig. 1. Molecular mass determination by MALLS. In gray (left
axis) is shown the UV absorption pro¢le at 280 nm and in black
(right axis) the molecular mass as determined by MALLS using the
protein concentration calculated by the refractive index.
Fig. 2. Shape determination of SipA446ÿ684 by SAXS. Data are
shown for a SipA446ÿ684 concentration of 624 WM (15.9 mg/ml).
(A) Guinier plot of SipA446ÿ684. (B) Length distribution function,
P(r), of SipA446ÿ684.
Fig. 3. CD spectrum of SipA446ÿ684.
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95 Aî . As a reference, the theoretical Rg of a monomeric glob-
ular protein of molecular mass 25.6 kDa is 12.4 Aî with a
maximum diameter of 39.2 Aî . The Rg of a long uniform
rod of length 95 Aî is 27 Aî . The scattering data for SipA446ÿ684
were also run through a shape determination program (DAM-
MIN [15]), which yielded an elongated, roughly cylindrically
shaped molecule with end-to-end lengths ranging between 85
and 95 Aî and diameters ranging between 15 and 25 Aî .
A good candidate for a stable protein with an elongated
shape is one with a coiled-coil domain composed of two or
more helices. To test this idea, we determined the CD spec-
trum of SipA446ÿ684 (Fig. 3), which shows signi¢cant K-helical
content, indicated by the characteristic double minimum at
208 and 222 nm. SipA446ÿ684 is about 54% helical, which cor-
responds to 127 residues. The protein sequence was run
through secondary structure prediction programs, which pre-
dicted a predominantly helical conformation for residues 93^
216, a span of 123 residues, and residues 25^30. To be 95 Aî in
length, a standard K-helix must contain 63 amino acids. The
biophysical and secondary structure prediction data for
SipA446ÿ684 (Fig. 4) support the existence of a coiled-coil do-
main composed of two antiparallel helices, each consisting of
about 60 residues, which span a length of 95 Aî .
4. Discussion
F-actin can be viewed either as a left-handed single helix
with a rise per monomer of 27.5 Aî and 13 subunits that repeat
after six turns or as a right-handed double helix with a rise per
monomer on each helix strand of 55 Aî and a repeat every
72 nm [17]. The maximum diameter of the ¢lament varies
between 90 and 95 Aî . Given the highly elongated nature of
SipA446ÿ684, it is possible that the protein spans two neighbor-
ing actin monomers in a ¢lament. Any potential modelling of
this interaction should take into account the previous ¢nding
that binding to F-actin occurs in a 1:1 molar ratio of
SipA446ÿ684 to actin monomer and the observation that
SipA446ÿ684 is monomeric and thus does not bind to itself.
Two models of how SipA446ÿ684 might interact with F-actin
are depicted in Fig. 5A. In model [I], SipA446ÿ684 binds adja-
cent actin monomers across the double-stranded right-handed
helix on both faces and predicts a SipA446ÿ684 to actin mono-
mer ratio of n31:n, which for long ¢laments is essentially 1:1.
If SipA446ÿ684 molecules also bind with one end to the last
actin monomer at the pointed and/or barbed end, the pre-
dicted molar ratio changes to n :n or n+1:n. A rigid coiled-
coil domain spanning actin monomers across the double-
stranded ¢lament helix would ensure rigidity and stabilization
of the ¢lament. This is in accordance with the straightening
out phenomenon observed for F-actin ¢laments in the pres-
ence of SipA446ÿ684 and the inhibition of F-actin depolymer-
ization at low ionic strength. In model [II], SipA446ÿ684 is
shown binding to two consecutive actin monomers in the
Fig. 4. Secondary structure prediction of SipA446ÿ684. The top two
panels show the probability of occurrence of K-helical secondary
structure as predicted by the Chou and Fasman method (CF, top
panel) and Garnier^Osguthorpe^Robson method (GOR, middle
panel) of the Wisconsin Package Version 10.0, Genetics Computer
Group (GCG) [19]. In the top panel, weaker probabilities have a
prediction value of 0.5 and strong probabilities a value of 1. The
last panel (PROF) shows the probability of helical secondary struc-
ture according to the Prof method developed by Ouali, M. and
King, R.D [20].
Fig. 5. Possible models of SipA446ÿ684 action on F-actin. (A) Shown
is an unwound portion of F-actin, where actin monomers are drawn
as rounded squares with a groove indicating the nucleotide-binding
site. The rigid domain of SipA446ÿ684, which contains a coiled-coil
domain of length 95 Aî consisting of two antiparallel helices, is
shown as an elongated rod. In model [I], SipA446ÿ684 spans two ad-
jacent actin monomers across the double-stranded helix both in the
front (dark gray) and in the back (light gray). Model [II] shows
SipA446ÿ684 spanning two consecutive actin monomers in the same
strand. SipA446ÿ684 molecules might bind to the pointed and/or
barbed end in either model (dashed, un¢lled rods). (B) SipA446ÿ684
may decrease the actin critical concentration necessary for ¢lament
formation by shifting the equilibrium towards the trimeric actin nu-
cleus. This could occur by multiple pathways for model [I], depend-
ing on whether SipA446ÿ684 binds the dimeric actin, and also on the
sequence of SipA446ÿ684 and actin monomer binding to the actin
dimer. For model [II] one SipA446ÿ684 molecule is shown binding to
the trimer after it has formed.
FEBS 24150 22-9-00
K. Mitra et al./FEBS Letters 482 (2000) 81^84 83
same strand of the double-stranded ¢lament helix, giving a
predicted SipA446ÿ684 to actin molar ratio of n32:n. If upto
four additional SipA446ÿ684 molecules bind to the barbed and
pointed ends, the binding ratio could vary from n31:n to
n+2:n. In this model, stabilization of the ¢lament by
SipA446ÿ684 could occur by inducing conformational changes
in the actin, such that interactions across the two strands of
the double helix are strengthened, consequently stabilizing the
¢lament overall. It should be noted that both models imply
the presence of more than one actin-binding site on
SipA446ÿ684 and consequently two or more SipA446ÿ684 bind-
ing sites on each actin monomer. Fig. 5B attempts to account
for the decrease in actin critical concentration by SipA446ÿ684,
which could be a consequence of stabilization of the trimeric
actin nucleus [18]. This would shift the equilibrium from
monomer to oligomer, thereby lowering the critical concen-
tration. For model [I] several pathways of stabilization of the
nucleus are conceivable. It has been observed that SipA446ÿ684
does not bind to monomeric actin [7], suggesting that either
SipA446ÿ684 binds to and stabilizes an actin dimer (2) and
subsequently the trimeric actin nucleus or that SipA446ÿ684
directly stabilizes the trimeric actin nucleus (1) without bind-
ing an actin dimer. Pathway (2) has two possible branches
depending on the order of SipA446ÿ684 and actin monomer
binding to the stabilized dimer. In (2a) actin binds ¢rst and
the trimer is further stabilized by binding a SipA446ÿ684 mol-
ecule, whereas in (2b) another SipA446ÿ684 molecule binds to
the stabilized dimer to which an actin monomer subsequently
binds. For model [II] only one SipA446ÿ684 stabilizes the tri-
meric actin nucleus, after it has formed. We have synthesized
the biophysical data describing structural characteristics of
SipA446ÿ684 into two possible models, which are consistent
with the biochemical e¡ects of SipA446ÿ684 on actin. Although
both models are consistent with the biophysical data described
here, model [I] might explain better and more simply how
SipA446ÿ684 lends stability to F-actin than does model [II].
Future mutagenesis mapping to determine binding sites, de-
tailed analysis of the stoichiometry of SipA446ÿ684 binding to
¢laments of di¡erent lengths, in depth study of the binding of
SipA446ÿ684 to actin nuclei and structural studies will be
needed to corroborate either of the models presented here.
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